CN Patent

CN107973783B — 作为erk抑制剂的苯胺嘧啶衍生物

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2024-09-06 · 2y expired

What this patent protects

本申请属于医药化学领域，具体而言，涉及新的作为ERK抑制剂的苯胺嘧啶衍生物及其药学上可接受的盐，具体涉及式I所示化合物及其药学上可接受的盐、其药物组合物、及其用于治疗受益于ERK抑制的疾病的方法。

USPTO Abstract

本申请属于医药化学领域，具体而言，涉及新的作为ERK抑制剂的苯胺嘧啶衍生物及其药学上可接受的盐，具体涉及式I所示化合物及其药学上可接受的盐、其药物组合物、及其用于治疗受益于ERK抑制的疾病的方法。

Drugs covered by this patent

mobocertinib-succinate (MOBOCERTINIB SUCCINATE)

Patent Metadata

Patent number: CN107973783B
Jurisdiction: CN
Classification: —
Expires: 2024-09-06
Drug substance claim: No
Drug product claim: No
Assignee: Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.